| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.34 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |